GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » St Pharm Co Ltd (XKRX:237690) » Definitions » Deferred Tax

St Pharm Co (XKRX:237690) Deferred Tax : ₩9,050 Mil (TTM As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is St Pharm Co Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

St Pharm Co's change in deferred tax for the three months ended in Mar. 2025 was ₩851 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2025 was ₩9,050 Mil.


St Pharm Co Deferred Tax Historical Data

The historical data trend for St Pharm Co's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

St Pharm Co Deferred Tax Chart

St Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,670.00 -2,117.18 1,721.31 5,830.84 10,282.75

St Pharm Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,084.23 -18.30 1,209.03 7,007.78 851.41

St Pharm Co Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩9,050 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


St Pharm Co Deferred Tax Related Terms

Thank you for viewing the detailed overview of St Pharm Co's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.


St Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
Teheran Road 78, Gangnam-gu, 7F MSA Building, Daechi-dong, Seoul, KOR, 891-43
St Pharm Co Ltd offers custom manufacturing services of Active pharmaceutical ingredients and their intermediates for their use in pharmaceutical development and be compliant to cGMP, requirements. The firm's business areas include commercial manufacturing of new drug development, manufacturing of generic active pharmaceutical ingredients, fine chemical's business and development of oligonucleotide therapeutics. The company's products comprise small molecule active pharmaceutical ingredients, Anti-cancer, Anti- coagulant active pharmaceutical ingredients, etc.

St Pharm Co Headlines

No Headlines